Cargando…
Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410060/ https://www.ncbi.nlm.nih.gov/pubmed/30781899 http://dx.doi.org/10.3390/toxins11020115 |
_version_ | 1783402145409662976 |
---|---|
author | Field, Malgorzata Splevins, Andrew Picaut, Philippe van der Schans, Marcel Langenberg, Jan Noort, Daan Snyder, Daniel Foster, Keith |
author_facet | Field, Malgorzata Splevins, Andrew Picaut, Philippe van der Schans, Marcel Langenberg, Jan Noort, Daan Snyder, Daniel Foster, Keith |
author_sort | Field, Malgorzata |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6410060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64100602019-04-01 Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients Field, Malgorzata Splevins, Andrew Picaut, Philippe van der Schans, Marcel Langenberg, Jan Noort, Daan Snyder, Daniel Foster, Keith Toxins (Basel) Correction MDPI 2019-02-13 /pmc/articles/PMC6410060/ /pubmed/30781899 http://dx.doi.org/10.3390/toxins11020115 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Field, Malgorzata Splevins, Andrew Picaut, Philippe van der Schans, Marcel Langenberg, Jan Noort, Daan Snyder, Daniel Foster, Keith Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients |
title | Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients |
title_full | Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients |
title_fullStr | Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients |
title_full_unstemmed | Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients |
title_short | Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients |
title_sort | correction: field, m. et al. abobotulinumtoxina (dysport(®)), onabotulinumtoxina (botox(®)), and incobotulinumtoxina (xeomin(®)) neurotoxin content and potential implications for duration of response in patients |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410060/ https://www.ncbi.nlm.nih.gov/pubmed/30781899 http://dx.doi.org/10.3390/toxins11020115 |
work_keys_str_mv | AT fieldmalgorzata correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT splevinsandrew correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT picautphilippe correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT vanderschansmarcel correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT langenbergjan correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT noortdaan correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT snyderdaniel correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT fosterkeith correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients |